Skip to content

Clinical trial on the effectiveness of Chinese herbal Xiangbin Fang on the recovery from gastrointestinal function after abdominal surgery

Research on Chinese Traditional Medicine for Fast Recovery of Postoperative Gastrointestinal Function

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004156
Enrollment
Unknown
Registered
2014-01-03
Start date
2014-09-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

medium and large size abdominal surgery

Interventions

A (Xiangbin Fang):placebo
B Xiangbin Fang:Oral Xiangbin Fang
A (Xiangbin granule):Xiangbin granule
B (placebo):placebo

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Part one: 1) Patients with gastric and colorectal cancerHysteromyoma hysterectomy after surgery; 2) Aged from 40 to 75 years old; Gastroenterological surgery patients aged from 40 to 80 years old; 3) The duration of operation is with 1 to 4 hours; 4) The anesthesia time is within 1.5 to 4.5 hours; 5) The TCM syndrome is identified as qi stagnation fu-organ stuff; 6) Willing to sign an informed consent document. Part two: 1) patients underwent gynecologic surgery, age 40~75 years; 2) Gastroenterological surgery patients aged from 40 to 80 years old; 3) The duration of operation is with 0.5 to 5 hours; 4) The anesthesia time is within 1 to 5 hours; 5) The TCM syndrome is identified as qi stagnation fu-organ stuff; 6) Willing to sign an informed consent document.

Exclusion criteria

Exclusion criteria: 1) Advanced malignant tumor cachexia, extremely weak; 2) Patients of malignant tumor who needs extended radical operation; 3) patients combined with cardiovascular, liver, kidney, brain, lung and other serious diseases; 4) Bad drug control of Hypertension, diabetes; 5) Patients with mental disease; 6) Patients with allergies to the intervention; 7) Pregnant or breast-feeding women; 8) Severe malnutrition, serum albumin<21g/L, prealbumin< 0.1g/L; 9) Re-abdominal surgery and severe intestinal adhesion; 10) Blood loss more than 400 milliliters during the surgery; 11) Occuring serious complications within 6 hours after the surgery, e.g. multiple organ dysfunction; 12) Emergency surgery; 13) Prokinetic drugs must be taken after operation; 14) Patient participating other clinical study or having participated other clinical study in the last one month; 15) Patient considered inappropriate to participate the study by clinical investigators.

Design outcomes

Primary

MeasureTime frame
time to first bowel sounds;time to first flatus;time to first defecation;Gastrointestinal dynamics;gastrointestinal hormone;

Countries

China

Contacts

Public ContactChen Zhiqiang

The 2nd Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

zhi57@163.com+86 020 81887233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026